Adventist Health System/ West
In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 12, 2025), Adventist Health System/ West reported 8 stock positions worth $646.5 million. Its top holding was Vanguard S&P 500 ETF (VOO) at 40.9% of the portfolio, followed by iShares Core S&P 500 ETF (IVV, 18.6%) and Vanguard Russell 1000 Value (VONV, 8.7%). Compared with Q3 2024, it opened 1 new position and reduced 1. The biggest buy was a new position in Vanguard S&P 500 ETF (VOO) and the biggest sale iShares Core S&P 500 ETF (IVV, shares −69%).
- Most Recent 13F
- Q2 2026
- Location
- Roseville, CA
- CIK
- 0001802516
- Portfolio Value
- $646.5M (Q4 2024)
- SEC Filing
- 0001172661-25-000678 ↗ filed Feb 12, 2025
Holdings Value
Holdings 8 stocks · $646.5M
| VOO Vanguard S&P 500 ETF | 40.88% | 490,500 | $264.3M | New |
| IVV iShares Core S&P 500 ETF | 18.62% | 204,550 | $120.4M | Reduce -68.7% |
| VONV Vanguard Russell 1000 Value | 8.71% | 692,800 | $56.3M | No change |
| IEMG iShares Core MSCI Emerging | 8.62% | 1,067,519 | $55.7M | No change |
| VEA Vanguard Ftse Developed ETF | 8.37% | 1,131,440 | $54.1M | No change |
| VTIP Vanguard Short-Term Tips | 7.24% | 966,530 | $46.8M | No change |
| VOT Vngrd Mrngstr MC GRW ETF-Usd | 5.15% | 131,150 | $33.3M | No change |
| VBK Van Morst SML-Cap Gro-Usd Inc. | 2.41% | 55,720 | $15.6M | No change |
Portfolio Sells Q3 2024 → Q4 2024
| IVV iShares Core S&P 500 ETF | Reduce -68.7% | 18.62% | −39.35 |
Portfolio Buys Q3 2024 → Q4 2024
| VOO Vanguard S&P 500 ETF | New | 40.88% | +40.88 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 12 | $638.1M | IVV, VEA, VONV, IXUS, ITOT |
| Q1 2026 | 13 | $563.9M | IVV, VEA, VONV, IXUS, ITOT |
| Q4 2025 | 8 | $595.0M | IVV, VEA, VONV, ITOT, VTIP |
| Q3 2025 | 8 | $613.9M | VOO, VEA, ITOT, VONV, VTIP |
| Q2 2025 | 8 | $673.3M | VOO, IVV, VEA, VONV, EMXC |
| Q1 2025 | 8 | $633.7M | VOO, IVV, IEMG, VEA, VONV |
| Q4 2024 | 8 | $646.5M | VOO, IVV, VONV, IEMG, VEA |
| Q3 2024 | 7 | $650.2M | IVV, IEMG, VEA, VONV, VTIP |
| Q2 2024 | 7 | $615.9M | IVV, IEMG, VEA, VONV, VTIP |
| Q1 2024 | 5 | $556.2M | IVV, IEFA, IEMG, VONV, VTIP |